Cellebrite DI (CLBT) Non Operating Investment Income (2021 - 2025)

Cellebrite DI's Non Operating Investment Income history runs 5 years deep, the most recent figure standing at $5.5 million for Q4 2025.

• In Q4 2025, Non Operating Investment Income rose 31.08% year-over-year to $5.5 million; the TTM figure through Dec 2025 stood at $24.2 million (up 107.27% YoY), while the FY2025 annual figure was $24.2 million, up 107.27% from the prior year.
• Non Operating Investment Income was $5.5 million for Q4 2025 at Cellebrite DI, up from $5.3 million in the prior quarter.
• In the past five years, Non Operating Investment Income ranged from a high of $7.1 million in Q1 2025 to a low of -$224.0 million in Q3 2024.
• Historically, Non Operating Investment Income has averaged -$18.8 million across 5 years, with a median of -$47500.0 in 2023.
• The sharpest annual moves came in 2023 and 2024: Non Operating Investment Income jumped 133.46% in 2023, then sank 257550.57% in 2024.
• A 5-year view of Non Operating Investment Income shows it stood at $120000.0 in 2021, then sank by 63.33% to $44000.0 in 2022, then plunged by 62245.45% to -$27.3 million in 2023, then jumped by 115.25% to $4.2 million in 2024, then soared by 31.08% to $5.5 million in 2025.
• The last three Non Operating Investment Income figures came in at $5.5 million (Q4 2025), $5.3 million (Q3 2025), and $6.4 million (Q2 2025), per Business Quant data.